Kodiak Sciences (KOD) Cash from Operations (2017 - 2026)
Kodiak Sciences (KOD) posted Cash from Operations of 40009000.0 for Q1 2026, down 1.6% on a QoQ basis from 39378000.0 in Q4 2025, and down 37.6% year-over-year from 64113623.2 in Q1 2025.
Kodiak Sciences (KOD) Cash from Operations (2017 - 2026) Analysis & Trends
Kodiak Sciences' Cash from Operations history runs 10 years deep, the most recent figure standing at 40009000.0 for Q1 2026.
- Quarterly Cash from Operations fell 37.6% year-over-year to 40009000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 146940000.0 (down 37.61% YoY) and the FY2025 annual result came in at 136008000.0, down 15.95% from the prior year.
- Cash from Operations was 40009000.0 for Q1 2026 at Kodiak Sciences, down from 39378000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 21149000.0 in Q3 2024 and bottomed at 55137000.0 in Q2 2022.
- A 5-year average of 38470588.24 and a median of 39378000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations surged 41.51% — and 2025, when it slumped 55.23%.
- Kodiak Sciences' Cash from Operations stood at 55116000.0 in 2022, then soared by 41.51% to 32239000.0 in 2023, then gained by 6.79% to 30051000.0 in 2024, then tumbled by 31.04% to 39378000.0 in 2025, then decreased by 1.6% to 40009000.0 in 2026.
- Business Quant data shows KOD's Cash from Operations at 40009000.0 in Q1 2026, 39378000.0 in Q4 2025, and 32830000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | -40.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.01 Mn |
| Mar 31, 2026 | -40.01 Mn |
| Dec 31, 2025 | -39.38 Mn |
| Dec 31, 2025 | -39.38 Mn |
| Sep 30, 2025 | -32.83 Mn |
| Sep 30, 2025 | -32.83 Mn |
| Jun 30, 2025 | -34.72 Mn |
| Jun 30, 2025 | -34.72 Mn |
| Mar 31, 2025 | -29.08 Mn |
| Mar 31, 2025 | -29.08 Mn |
| Dec 31, 2024 | -30.05 Mn |
| Dec 31, 2024 | -30.05 Mn |
| Sep 30, 2024 | -21.15 Mn |
| Sep 30, 2024 | -21.15 Mn |
| Jun 30, 2024 | -26.50 Mn |
| Jun 30, 2024 | -26.50 Mn |
| Mar 31, 2024 | -39.60 Mn |
| Mar 31, 2024 | -39.60 Mn |
| Dec 31, 2023 | -32.24 Mn |
| Dec 31, 2023 | -32.24 Mn |